EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Unexpected brain metastases from neuroendocrine prostate cancer detected by [18F]fluorocholine PET/CT: a case report

Yassir Benameur, Mohcine Hommadi, Omar Ait Sahel, Salah Nabih Oueriagli, Ikram Zahfir, Meryem Aboussabr, Jaafar El Bakkali, Abderrahim Doudouh

Frontiers in Medicine · 03.03.2026 · 13

DOI: 10.3389/fmed.2026.1722967 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Medicine, online erschienen am 03.03.2026. Verfasst von Yassir Benameur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat, Morocco. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine prostate cancer (NEPC) is a rare and aggressive variant of prostate carcinoma, often associated with atypical metastatic spread and poor prognosis. Brain metastases from NEPC are exceptional and may pose significant diagnostic challenges. We report the case of a 59-year-old man referred for initial staging of prostate cancer after a transrectal ultrasound-guided biopsy that initially demonstrated poorly differentiated adenocarcinoma. Whole-body [ 18 F]fluorocholine positron emission tomography/computed tomography (PET/CT) revealed subcentimetric hypermetabolic foci in the left frontal and left temporal cortex and in the left cerebellar hemisphere, suggestive of brain metastases. Pelvic lymphadenopathy was also identified, with no evidence of bone or other visceral involvement. Subsequent histopathological re-evaluation of the initial biopsy, including extended immunohistochemical analysis, demonstrated a neuroendocrine (small cell) component. The patient underwent stereotactic radiotherapy for the cerebral lesions and localized radiotherapy for the primary prostatic tumor. This case underscores the diagnostic value of [ 18 F]fluorocholine PET/CT in detecting unexpected metastatic sites in neuroendocrine prostate carcinoma. Early identification of central nervous system involvement may have therapeutic and prognostic implications, emphasizing the need for molecular imaging in atypical or aggressive prostate cancer phenotypes.

Schlagwörter

Stichwörter der Autor:innen

[18F]fluorocholine PET/CTbrain metastasescase reporthybrid imagingmolecular imagingneuroendocrine prostate cancersmall cell carcinoma

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, Rabat, Morocco.
  • Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Department of Radiotherapy, Mohammed V Military Teaching Hospital, Rabat, Morocco.

Zitieren

APA

Benameur, Y., Hommadi, M., Sahel, O. A., Oueriagli, S. N., Zahfir, I., Aboussabr, M., Bakkali, J. E., & Doudouh, A. (2026). Unexpected brain metastases from neuroendocrine prostate cancer detected by [18F]fluorocholine PET/CT: a case report. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1722967

Vancouver

Benameur Y, Hommadi M, Sahel OA, Oueriagli SN, Zahfir I, Aboussabr M, et al. Unexpected brain metastases from neuroendocrine prostate cancer detected by [18F]fluorocholine PET/CT: a case report. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1722967

BibTeX
@article{Benameur2026,
  author = {Benameur, Yassir and Hommadi, Mohcine and Sahel, Omar Ait and Oueriagli, Salah Nabih and Zahfir, Ikram and Aboussabr, Meryem and Bakkali, Jaafar El and Doudouh, Abderrahim},
  title = {Unexpected brain metastases from neuroendocrine prostate cancer detected by [18F]fluorocholine PET/CT: a case report},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1722967}
}
Kostenlos starten →